Cravatt Benjamin

Alnylam Pharmaceuticals Inc · Director

Cravatt Benjamin is listed in public filings as director. This Cravatt Benjamin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Alnylam Pharmaceuticals Inc (ALNY). Investors use Cravatt Benjamin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Alnylam Pharmaceuticals IncALNY$1.3M4.4k sharesGrant / ExerciseJun 1, 2026$1.3M4.4k shares$295.63--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Historical actions before the latest disclosure date will appear here after more snapshots are available.